New fused benzazepine as selective D3 receptor antagonists.: Synthesis and biological evaluation.: Part 2:: [g]-Fused and hetero-fused systems

被引:14
作者
Micheli, Fabrizio [1 ]
Bonanomi, Giorgio [1 ]
Braggio, Simone [1 ]
Capelli, Anna Maria [2 ]
Damiani, Federica [3 ]
Di Fabio, Romano [1 ]
Donati, Daniele [1 ]
Gentile, Gabriella [1 ]
Hamprecht, Dieter [1 ]
Perini, Ornella [2 ]
Petrone, Marcella [1 ]
Tedesco, Giovanna [2 ]
Terreni, Silvia [1 ]
Worby, Angela
Heidbreder, Christian [1 ]
机构
[1] GlaxoSmithKline Inc, Psychiat Ctr Excellence Drug Discovery, I-37135 Verona, Italy
[2] Mol Discovery Res, I-37135 Verona, Italy
[3] European Patent Off, Munich, Germany
关键词
rat; dopamine; D-3; antagonists; selective; drug dependence;
D O I
10.1016/j.bmcl.2007.12.042
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and the SAR of a new series of potent and selective dopamine D-3 receptor antagonists is reported. The new scaffolds of the [g]-fused and the hetero-fused tricyclic benzazepine are here reported together with their pharmacokinetic profile. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:908 / 912
页数:5
相关论文
共 6 条
  • [1] Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties
    Ertl, P
    Rohde, B
    Selzer, P
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (20) : 3714 - 3717
  • [2] Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SB-414796):: A potent and selective dopamine D3 receptor antagonist
    Macdonald, GJ
    Branch, CL
    Hadley, MS
    Johnson, CN
    Nash, DJ
    Smith, AB
    Stemp, G
    Thewlis, KM
    Vong, AKK
    Austin, NE
    Jeffrey, P
    Winborn, KY
    Boyfield, I
    Hagan, JJ
    Middlemiss, DN
    Reavill, C
    Riley, GJ
    Watson, JM
    Wood, M
    Parker, SG
    Ashby, CR
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (23) : 4952 - 4964
  • [3] MICHELI, 2006, RECENT PATENTS CNS D, V1, P271
  • [4] MICHELI F, 2007, C J MED CHEM, V50, P5076
  • [5] Reavill C, 2000, J PHARMACOL EXP THER, V294, P1154
  • [6] Recent advances towards the discovery of dopamine receptor ligands
    Zhang, Ao
    Kan, Ying
    Li, Fuying
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (05) : 587 - 630